Log in to save to my catalogue

Astragaloside IV, a novel antioxidant, prevents glucose-induced podocyte apoptosis in vitro and in v...

Astragaloside IV, a novel antioxidant, prevents glucose-induced podocyte apoptosis in vitro and in v...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1325029173

Astragaloside IV, a novel antioxidant, prevents glucose-induced podocyte apoptosis in vitro and in vivo

About this item

Full title

Astragaloside IV, a novel antioxidant, prevents glucose-induced podocyte apoptosis in vitro and in vivo

Publisher

United States: Public Library of Science

Journal title

PloS one, 2012-06, Vol.7 (6), p.e39824-e39824

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

Glucose-induced reactive oxygen species (ROS) production initiates podocyte apoptosis, which represents a novel early mechanism leading to diabetic nephropathy (DN). Here, we tested the hypothesis that Astragaloside IV(AS-IV) exerts antioxidant and antiapoptotic effects on podocytes under diabetic conditions. Apoptosis, albuminuria, ROS generation,...

Alternative Titles

Full title

Astragaloside IV, a novel antioxidant, prevents glucose-induced podocyte apoptosis in vitro and in vivo

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_1325029173

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1325029173

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0039824

How to access this item